San Diego, Ca., USA – Qualcomm Incorporated, a developer of wireless technologies, announced the election of Susan Hockfield to its board of directors.[break]
Dr. Hockfield’s career spans more than 30 years as a leader in biomedical science research, and she served as president of the Massachusetts Institute of Technology (MIT) until July 2012, where she also holds a faculty appointment as professor of neuroscience.
Dr. Hockfield has distinguished herself both as a scientist and a leader of one of the world’s premier science and engineering institutions. Following her university studies, Dr. Hockfield was a National Institutes of Health (NIH) postdoctoral fellow at the University of California at San Francisco, and then a member of the scientific staff of the Cold Spring Harbor Laboratory.
Joining the faculty of Yale University in 1985, Dr. Hockfield’s research focused on the development of the brain and on glioma, a deadly form of brain cancer, and pioneered the use of monoclonal antibody technology in brain research. At Yale, Dr. Hockfield emerged as a strong, innovative university leader, first as dean of its Graduate School of Arts and Sciences and later as provost, Yale’s chief academic and administrative officer.
From December 2004 until July 2012, Dr. Hockfield served as the 16th president of MIT and the first woman and the first life scientist to lead MIT. Dr. Hockfield championed breakthroughs emerging from the convergence of the life sciences with the engineering and physical sciences, in fields ranging from clean energy to cancer. Long an advocate for the research university as an engine of innovation and economic growth, Dr. Hockfield also worked to shape emerging national policy on energy technology and next - July 11, 2012, San Diego, Ca., USA – Qualcomm Incorporated, a developer of wireless technologies, announced the election of Susan Hockfield to its board of directors.
Article continues below
]
Dr. Hockfield’s career spans more than 30 years as a leader in biomedical science research, and she served as president of the Massachusetts Institute of Technology (MIT) until July 2012, where she also holds a faculty appointment as professor of neuroscience.
Dr. Hockfield has distinguished herself both as a scientist and a leader of one of the world’s premier science and engineering institutions. Following her university studies, Dr. Hockfield was a National Institutes of Health (NIH) postdoctoral fellow at the University of California at San Francisco, and then a member of the scientific staff of the Cold Spring Harbor Laboratory.
Joining the faculty of Yale University in 1985, Dr. Hockfield’s research focused on the development of the brain and on glioma, a deadly form of brain cancer, and pioneered the use of monoclonal antibody technology in brain research. At Yale, Dr. Hockfield emerged as a strong, innovative university leader, first as dean of its Graduate School of Arts and Sciences and later as provost, Yale’s chief academic and administrative officer.
From December 2004 until July 2012, Dr. Hockfield served as the 16th president of MIT and the first woman and the first life scientist to lead MIT. Dr. Hockfield championed breakthroughs emerging from the convergence of the life sciences with the engineering and physical sciences, in fields ranging from clean energy to cancer. Long an advocate for the research university as an engine of innovation and economic growth, Dr. Hockfield also worked to shape emerging national policy on energy technology and next-generation manufacturing.
Dr. Hockfield earned a Bachelor of Arts in biology from the University of Rochester and a Ph.D. from Georgetown University at the School of Medicine, while carrying out her dissertation research at the NIH. ■